-
Hospitals should provide pertussis vaccines to their health care workers free of charge, but should still treat employees with antibiotics if they have unprotected exposure to patients with pertussis and work with patients at high risk, such as young infants, a federal vaccine advisory panel says.
-
The headlines once again warn of a new superbug threatening mankind.
-
Of 150 patients with hematogenous vertebral osteomyelitis, 92 (61%) underwent biopsy 60 (65%) needle and 32 (35%) open. Imaging studies revealed discitis in 75%, vertebral osteomyelitis in 70%, and epidural abscess in 44% of patients.
-
A study compared culture- and PCR-based bacterial identification methods among 85 children hospitalized at a single medical center with parapneumonic effusion in 2009.
-
Despite the recent gains achieved by multidisciplinary control programs, malaria still kills nearly 1 million people and causes almost 300 million symptomatic illnesses globally each year, with most of this burden borne by sub-Saharan Africa.
-
Linezolid is an oxazolidinone agent that has been shown to be effective for the treatment of infections caused by Gram-positive bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
-
Due to heightened surveillance of acute febrile illness in China, a severe illness associated with thrombocytopenia and multi-system organ involvement was recognized beginning in 2009.
-
Exposure to coccidioidomycosis in the laboratory can represent a significant hazard, resulting in serious and even fatal infection. In particular, opening culture plates in the lab, without appropriate precautions, can result in the aerosolization of artificially large numbers of arthroconodia.
-
In this issue: Anticholinergic drugs for COPD; pioglitazone for diabetes prevention; insulin degludec in Phase 3 trials; and FDA Actions.
-
